Shares of HIMS experienced a dramatic decline today following the unexpected withdrawal of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending its stock price plummeting by more than fifteen percent. The reason for the breakdown of the partnership